News

  • You are here:

AbbVie and SFI invest €7.5 million in  new APC Microbiome Institute research collaboration in Crohn’s disease

21st November 2015

2015AbbVie Dublin Castle Cork

The APC Microbiome Institute is delighted to announce a €7.5m investment by Science Foundation Ireland and AbbVie for a five-year research collaboration in the area of Crohn’s disease. The programme, to be led by APC Director Prof Fergus Shanahan and Project Leader, Dr Ken Nally, will support 11 new research positions at the APC.

Commenting on the announcement, Prof Mark Ferguson, Director General of Science Foundation Ireland and Chief Scientific Adviser to the Government of Ireland said, “Autoimmune diseases like Crohn’s are common and debilitating. By partnering our leading researchers with those in a major pharmaceutical company like AbbVie we can hopefully accelerate the discovery of new knowledge which will lead to improved treatments and outcomes for patients. We are delighted that AbbVie – a global company – choose to partner with Irish researchers – this is a positive reflection of the quality and relevance of Irish scientific research – excellence and impact.”

AbbVie employs more than 500 people at five manufacturing and commercial sites across Ireland. Together with its wholly-owned subsidiary, Pharmacyclics, AbbVie employs more than 28,000 people worldwide and markets medicines in more than 170 countries.

Jim Sullivan, Ph.D., Vice President of Pharmaceutical Discovery at AbbVie, says that “AbbVie has a long history in Ireland and the country has contributed greatly to our global success. We are impressed with the high quality immunology research ongoing across academia in Ireland.  Partnering with the leading researchers in autoimmune disease will foster continued innovation in one of our most important therapeutic areas. We hope to unlock the potential for significant advancements for patients with serious autoimmune disease.”

Prof Fergus Shanahan added that the AbbVie/APC venture is “a wonderful match, blending industry and academe with complementary technology and expertise”.

Photo (left to right): Dr Ken Nally, APC Microbiome Institute , Project Leader, Professor Mark Ferguson, Director General Science Foundation Ireland & Chief Scientific Adviser to the Government of Ireland, Mr Richard Bruton TD, Minister for Jobs, Dr Jim Sullivan,Vice President of Pharmaceutical Discovery at AbbVie, Mr Todd Manning, General Manager, Abbvie Ireland and Professor Fergus Shanahan, Director, APC Microbiome Institute, UCC.

 

 

Link to SFI Press Release